SOUTH SAN FRANCISCO, Calif., Feb. 28, 2011 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGND), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report fourth quarter and fiscal year-end 2010 results, along with guidance for 2011, on Thursday, March 3, 2011. A conference call and webcast hosted by OXiGENE management will begin at 4:30 pm EST (1:30 p.m. PST).
